Literature DB >> 4029555

Hepatic decompensation associated with hepatitis B e antigen clearance in chronic type B hepatitis.

I S Sheen, Y F Liaw, D I Tai, C M Chu.   

Abstract

To examine hepatic decompensation associated with acute exacerbation preceding hepatitis B e antigen clearance in chronic type B hepatitis, 376 patients with chronic hepatitis who were hepatitis B e antigen-positive were prospectively studied for up to 7 yr (mean 25 mo). Among the 165 patients who underwent hepatitis B e antigen clearance, 4 patients experienced hepatic decompensation and one of them eventually developed hepatic encephalopathy and died. The incidence of hepatic decompensation associated with hepatitis B e antigen clearance was 2.4%. We suggest that such an event in previously unrecognized chronic hepatitis B carriers could have been erroneously interpreted as acute or subacute hepatic failure, and that it might have been the result of a stronger enhancement of the host immune response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4029555     DOI: 10.1016/0016-5085(85)90566-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Score model for predicting acute-on-chronic liver failure risk in chronic hepatitis B.

Authors:  Fang-Yuan Gao; Yao Liu; Xiao-Shu Li; Xie-Qiong Ye; Le Sun; Ming-Fan Geng; Rui Wang; Hui-Min Liu; Xiao-Bing Zhou; Li-Li Gu; Yan-Min Liu; Gang Wan; Xian-Bo Wang
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 2.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

3.  Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.

Authors:  Nami Mori; Fumitaka Suzuki; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saito; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Mariko Kobayashi; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2012-02-29       Impact factor: 7.527

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 6.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

7.  Early entecavir treatment for chronic hepatitis B with severe acute exacerbation.

Authors:  Wei-Lun Tsai; Po-Hung Chiang; Hoi-Hung Chan; Huey-Shyan Lin; Kwok-Hung Lai; Jin-Shiung Cheng; Wen-Chi Chen; Feng-Woei Tsay; Huay-Min Wang; Tzung-Jiun Tsai; Hsien-Chung Yu; Ping-I Hsu
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

8.  Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation.

Authors:  Cheng-Yuan Peng; Chih-Bin Chen; Hsueh-Chou Lai; Wen-Pang Su; Po-Heng Chuang; Hong-Dar Isaac Wu; Long-Bin Jeng
Journal:  Hepatol Int       Date:  2010-12-16       Impact factor: 6.047

9.  Management of hepatitis B virus-related acute liver failure.

Authors:  Makoto Oketani; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi
Journal:  Clin J Gastroenterol       Date:  2014-01-24

10.  Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B.

Authors:  Corinna Jen-Hui Pan; Hui-Lin Wu; Stephanie Fang-Tzu Kuo; Jia-Horng Kao; Tai-Chung Tseng; Chen-Hua Liu; Pei-Jer Chen; Chun-Jen Liu; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2011-07-16       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.